Diagnosis, treatment, and outcome of patients with oesophagogastric cancer during the COVID-19 pandemic: national study.
Mark A BaxterKhurram Shahzad KhanLewis S GallCatherine SamuelsonCatherine McCollumRongkagorn ChuntamongkolLakshmi R NarramneniManaf Al-ZuabiGavin BryceHala E J ShareefMatthew ForshawRussell D PettyPublished in: The British journal of surgery (2023)
This national study has highlighted the adverse impact of COVID-19 on oesophagogastric cancer outcomes in Scotland. Patients presented with more advanced disease and a shift towards treatment with non-curative intent was observed, with a subsequent negative impact on overall survival.
Keyphrases
- papillary thyroid
- end stage renal disease
- coronavirus disease
- sars cov
- squamous cell
- newly diagnosed
- chronic kidney disease
- quality improvement
- ejection fraction
- type diabetes
- metabolic syndrome
- young adults
- weight loss
- replacement therapy
- childhood cancer
- respiratory syndrome coronavirus
- electronic health record
- glycemic control